Evidence map›Paper›PMID 33515105›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2021

Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study.

Piergiorgio Gaudioso, Daniele Borsetto, Giancarlo Tirelli, Margherita Tofanelli, Fiordaliso Cragnolini, Anna Menegaldo, Cristoforo Fabbris, Gabriele Molteni, Daniele Marchioni, Piero Nicolai and 12 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Prognostic value of changes in pre- and postoperative inflammatory blood markers in HPV-negative head and neck squamous cell carcinomas.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 2 countries.

Piergiorgio GaudiosoDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy.
Daniele BorsettoDepartment of ENT, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Giancarlo TirelliDepartment of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
Margherita TofanelliDepartment of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
Fiordaliso CragnoliniDepartment of Medical, Surgical and Health Sciences, Section of Otolaryngology, University of Trieste, Trieste, Italy.
Anna MenegaldoDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy.
Cristoforo FabbrisSection of Ear Nose and Throat (ENT), Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Gabriele MolteniSection of Ear Nose and Throat (ENT), Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Daniele MarchioniSection of Ear Nose and Throat (ENT), Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, Verona, Italy.
Piero NicolaiDepartment of Otorhinolaryngology-Head Neck Surgery, University of Brescia, Brescia, Italy.
Paolo BossiMedical Oncology Unit, Department of Medical Oncology, ASST Spedali Civili di Brescia, Brescia, Italy.
Andrea CiorbaENT Department, University Hospital of Ferrara, Ferrara, Italy.
Stefano PelucchiENT Department, University Hospital of Ferrara, Ferrara, Italy.
Chiara BianchiniENT Department, University Hospital of Ferrara, Ferrara, Italy.
Simone MauramatiDepartment of Otorhinolaryngology, University of Pavia, IRCCS Policlinico "San Matteo" Foundation, Pavia, Italy.
Marco BenazzoDepartment of Otorhinolaryngology, University of Pavia, IRCCS Policlinico "San Matteo" Foundation, Pavia, Italy.
Vittorio GiacomarraUnit of Otolaryngology, Azienda Ospedaliera "S. Maria degli Angeli", Pordenone, Italy.
Roberto Di CarloDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Padova, Italy.
Mantegh SethiDepartment of Otolaryngology, Leeds University Hospital, Leeds, UK.
Jerry PoleselUnit of Cancer Epidemiology, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy.
Jonathan FusseyDepartment of ENT/Head and Neck Surgery, Queen Elizabeth University Hospital Birmingham, Birmingham, UK.
Paolo Boscolo-RizzoDepartment of Neurosciences, Section of Otolaryngology, University of Padova, Treviso, Italy. paolo.boscolorizzo@units.it.ORCID http://orcid.org/0000-0002-4635-7959
University of Padua · ITUniversity of Ferrara · ITUniversity of Trieste · ITUniversity of Verona · ITUniversity of Pavia · ITAzienda Ospedaliera Santa Maria Degli Angeli · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITCambridge University Hospitals NHS Foundation Trust · GBCentro di Riferimento Oncologico · ITQueen Elizabeth Hospital Birmingham · GBUniversity of Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study is to evaluate the prognostic value of pre-treatment advanced lung cancer inflammation index (ALI) in patients with HPV-negative HNSCC undergoing up-front surgical treatment.

methodsThe present multi-centre, retrospective study was performed in a consecutive cohort of patients who underwent upfront surgery with or without adjuvant (chemo)-radiotherapy for head and neck squamous cell carcinoma (HNSCC). Patients were stratified by ALI, and survival outcomes were compared between groups. In addition, the prognostic value of ALI was compared with two other indices, the prognostic nutritional index (PNI) and systemic inflammatory index (SIM).

resultsTwo hundred twenty-three patients met the inclusion criteria (151 male and 72 female). Overall and progression-free survival were significantly predicted by ALI < 20.4 (HR 3.23, CI 1.51-6.90 for PFS and HR 3.41, CI 1.47-7.91 for OS). Similarly, PNI < 40.5 (HR = 2.43, 95% CI: 1.31-4.51 for PFS and HR = 2.40, 95% CI: 1.19-4.82 for OS) and SIM > 2.5 (HR = 2.51, 95% CI: 1.23-5.10 for PFS and HR = 2.60, 95% CI: 1.19-5.67 for OS) were found to be significant predictors. Among the three indices, ALI < 20.4 identified the patients with the worst 5-year outcomes. Moreover, patients with a combination of low PNI and low ALI resulted to be a better predictor of progression (HR = 5.26, 95% CI: 2.01-13.73) and death (HR = 5.68, 95% CI: 1.92-16.79) than low ALI and low PNI considered alone.

conclusionsOur results support the use of pre-treatment ALI, an easily measurable inflammatory/nutritional index, in daily clinical practice to improve prognostic stratification in surgically treated HPV-negative HNSCC.

Indexed as

AgedFemaleHumansLung NeoplasmsMaleMiddle AgedPneumoniaPrognosisProgression-Free SurvivalRetrospective StudiesSquamous Cell Carcinoma of Head and NeckAdvanced lung cancer inflammation indexHead and neck cancerInflammatory indexesNutritionSurvival

Identifiers

PMID33515105
PMCPMC8236476
OpenAlexW3123328587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.